Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-03 Purchase | 2023-04-04 5:10 pm | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 8,809 | $2.2157 | $19,518 | 26,809 (Direct) | View |
| 2023-03-16 Purchase | 2023-03-16 5:10 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 26,000 | $2.039 | $53,014 | 1,179,098 (Indirect Direct) | View |
| 2023-03-14 Purchase | 2023-03-15 5:25 pm | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 100,000 | $2.01 | $201,000 | 1,153,098 (Indirect Direct) | View |
| 2023-03-14 Sale | 2023-03-15 5:20 pm | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 100,000 | $2.01 | $201,000 | 201,666 (Direct) | View |
| 2023-03-13 Purchase | 2023-03-15 5:15 pm | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 70,000 | $2.0224 | $141,570 | 86,500 (Direct) | View |
| 2023-01-03 Sale | 2023-01-04 07:24 am | ORAMED PHARMACEUTICALS INC. | ORMP | Rabinowitz Michael Chief Commercial Officer | 13,325 | $12.55 | $167,195 | 126,143 (Direct) | View |
| 2021-11-01 Sale | 2022-05-10 5:30 pm | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 3,000 | $25.6 | $76,800 | 0 (Direct) | View |
| 2022-03-21 Sale | 2022-03-22 8:30 pm | ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director | 10,000 | $9.4096 | $94,096 | 46,661 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 120,000 | $0 | 1,578,098 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 53,500 | $0 | 468,166 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Derovan Netanel Chief Legal Officer | 20,500 | $0 | 149,500 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 27,000 | $0 | 301,333 (Direct) | View |
| 2023-05-26 Option Award | 2023-05-31 5:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 24,500 | $0 | 230,000 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-01 5:12 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 20,000 | $0 | 1,920,000 (Direct) | View |
Ownership | 2023-05-01 5:07 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 0 | $0 | 1,900,000 (Indirect) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 30,000 | $0 | 58,696 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Derovan Netanel Chief Legal Officer | 81,000 | $0 | 129,000 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 108,000 | $0 | 274,333 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 279,000 | $0 | 1,458,098 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 30,000 | $0 | 116,500 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 213,000 | $0 | 414,666 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 97,500 | $0 | 205,500 (Direct) | View |
| 2023-04-17 Option Award | 2023-04-20 06:00 am | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 30,000 | $0 | 56,809 (Direct) | View |
| 2022-10-27 Gift | 2022-10-28 9:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 25,000 | $0 | 1,053,098 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-10 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 20,000 | $4.08 | 28,696 (Direct) | View |
| 2022-08-08 Tax Withholding | 2022-08-10 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 9,304 | $8.77 | 28,696 (Direct) | View |
| 2022-08-08 Exercise | 2022-08-10 4:30 pm | N/A 2022-08-08 | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 20,000 | $0 | 28,696 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:01 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 12,000 | $0 | 16,500 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:01 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 12,000 | $0 | 18,000 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Derovan Netanel Chief Legal Officer | 30,000 | $0 | 48,000 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 118,000 | $0 | 301,666 (Direct) | View |
| 2022-08-01 Tax Withholding | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 12,631 | $8.36 | 1,078,098 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 160,000 | $0 | 1,078,098 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 42,000 | $0 | 166,333 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 12,000 | $0 | 18,000 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 39,000 | $0 | 108,000 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Rabinowitz Michael Chief Commercial Officer | 30,000 | $0 | 139,468 (Direct) | View |
| 2022-01-03 Option Award(A) | 2022-05-10 5:32 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 6,000 | $0 | 6,000 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-03 5:30 pm | N/A 2032-05-02 | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-02-17 Exercise | 2022-02-22 5:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director | 6,667 | $4.8 | 56,661 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 5:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director | 3,010 | $10.63 | 56,661 (Direct) | View |
| 2022-02-17 Exercise | 2022-02-22 5:30 pm | 2020-12-30 2030-01-08 | ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director | 6,667 | $0 | 56,661 (Direct) | View |
| 2022-02-11 Gift(A) | 2022-02-15 5:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director | 5,000 | $0 | 53,004 (Direct) | View |
| 2022-02-11 Gift | 2022-02-14 5:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director | 5,000 | $0 | 47,004 (Direct) | View |